Cardiotoxicity of the adjuvant trastuzumab in a Saudi population: clinical experience of a single institution
Adjuvant trastuzumab is currently an internationally standard for the treatment of localised breast cancer that over express HER2 with the most adverse effect being cardiotoxicity. We conducted this study to evaluate the cardiac safety of trastuzumab in clinical practice.
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2016-06-01
|
Series: | Forum of Clinical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1515/fco-2016-0007 |
_version_ | 1818191862274457600 |
---|---|
author | Hamed Rasha Hamdy Salim Khalid Alzahrani Abdullah Elsamany Shereef |
author_facet | Hamed Rasha Hamdy Salim Khalid Alzahrani Abdullah Elsamany Shereef |
author_sort | Hamed Rasha Hamdy |
collection | DOAJ |
description | Adjuvant trastuzumab is currently an internationally standard for the treatment of localised breast cancer that over express HER2 with the most adverse effect being cardiotoxicity. We conducted this study to evaluate the cardiac safety of trastuzumab in clinical practice. |
first_indexed | 2024-12-12T00:21:21Z |
format | Article |
id | doaj.art-0cb6c97c6923469aac094e5d8c895856 |
institution | Directory Open Access Journal |
issn | 1792-362X |
language | English |
last_indexed | 2024-12-12T00:21:21Z |
publishDate | 2016-06-01 |
publisher | Sciendo |
record_format | Article |
series | Forum of Clinical Oncology |
spelling | doaj.art-0cb6c97c6923469aac094e5d8c8958562022-12-22T00:44:43ZengSciendoForum of Clinical Oncology1792-362X2016-06-01721610.1515/fco-2016-0007fco-2016-0007Cardiotoxicity of the adjuvant trastuzumab in a Saudi population: clinical experience of a single institutionHamed Rasha Hamdy0Salim Khalid1Alzahrani Abdullah2Elsamany Shereef3Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Mansoura University, Egypt, Mansoura, EgyptCardiology, King Abdulla Medical City Makkah, Kingdom of Saudi Arabia Medical Oncology, Oncology Center of King Abdulla Medical City (KAMC), Makkah, Kingdom of Saudi Arabia Medical Oncology, Oncology Center of King Abdulla Medical City (KAMC), Makkah, Kingdom of Saudi ArabiaAdjuvant trastuzumab is currently an internationally standard for the treatment of localised breast cancer that over express HER2 with the most adverse effect being cardiotoxicity. We conducted this study to evaluate the cardiac safety of trastuzumab in clinical practice.https://doi.org/10.1515/fco-2016-0007cardiotoxicityadjuvant trastuzumabinbreast cancer |
spellingShingle | Hamed Rasha Hamdy Salim Khalid Alzahrani Abdullah Elsamany Shereef Cardiotoxicity of the adjuvant trastuzumab in a Saudi population: clinical experience of a single institution Forum of Clinical Oncology cardiotoxicity adjuvant trastuzumabin breast cancer |
title | Cardiotoxicity of the adjuvant trastuzumab in a Saudi population: clinical experience of a single institution |
title_full | Cardiotoxicity of the adjuvant trastuzumab in a Saudi population: clinical experience of a single institution |
title_fullStr | Cardiotoxicity of the adjuvant trastuzumab in a Saudi population: clinical experience of a single institution |
title_full_unstemmed | Cardiotoxicity of the adjuvant trastuzumab in a Saudi population: clinical experience of a single institution |
title_short | Cardiotoxicity of the adjuvant trastuzumab in a Saudi population: clinical experience of a single institution |
title_sort | cardiotoxicity of the adjuvant trastuzumab in a saudi population clinical experience of a single institution |
topic | cardiotoxicity adjuvant trastuzumabin breast cancer |
url | https://doi.org/10.1515/fco-2016-0007 |
work_keys_str_mv | AT hamedrashahamdy cardiotoxicityoftheadjuvanttrastuzumabinasaudipopulationclinicalexperienceofasingleinstitution AT salimkhalid cardiotoxicityoftheadjuvanttrastuzumabinasaudipopulationclinicalexperienceofasingleinstitution AT alzahraniabdullah cardiotoxicityoftheadjuvanttrastuzumabinasaudipopulationclinicalexperienceofasingleinstitution AT elsamanyshereef cardiotoxicityoftheadjuvanttrastuzumabinasaudipopulationclinicalexperienceofasingleinstitution |